Therapeutic Drug Monitoring Market Updates by 2031
MARKET INTRODUCTION
Therapeutic drug monitoring is branch of clinical chemistry and clinical pharmacology. It helps to measure and maintain uniform drug concentration in the patients' blood stream for better outcome. Therapeutic drug monitoring is part of personalized medicine where measurement of medication concentration in the blood stream is necessary. Therapeutic drug monitoring is basically used in case of very specific drug concentrations requirement.
MARKET DYNAMICS
Therapeutic drug monitoring market is anticipated to grow in the forecast period owing to driving factors such as rising demand for personalized medication treatment, advancements in research of pharmacogenomics and pharmacokinetics of drugs, rising prevalence of complex diseases like cancer (rheumatoid arthritis, non-Hodgkin lymphomas), respiratory diseases such as neonatal apnea, pulmonary asthma, embolism and chronic obstructive pulmonary disease (COPD). Rising investments in research and development infrastructure by private players and government will drive the therapeutic drug monitoring market in near future. However, high infrastructure cost and lack of skilled professionals are the restraints of the therapeutic drug monitoring market.
MARKET SCOPE
The "Global Therapeutic Drug Monitoring Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of therapeutic drug monitoring market with detailed market segmentation by product, technology, drug class, end user, and geography. The global therapeutic drug monitoring market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading therapeutic drug monitoring market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global therapeutic drug monitoring market is segmented on the basis of product, technology, drug class, and end user. Based on product, the market is segmented as Equipment and consumables. On the basis of technology, the global therapeutic drug monitoring market is segmented in to immunoassays, chromatography-Ms, radioimmunoassays, and others. By drug class, the market is segmented into antibiotic drugs, antiepileptic drugs, antiarrhythmic drugs, bronchodilator drugs, immunosuppressant drugs, psychoactive drugs, anti-cancer drugs, and other drugs. On the basis of end user, the global therapeutic drug monitoring market is divided into hospital laboratories, private laboratories and other laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global therapeutic drug monitoring market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The therapeutic drug monitoring market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting therapeutic drug monitoring market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the therapeutic drug monitoring market in these regions.
By Product
By Technology
By Drug Class
By End User
MARKET PLAYERS
The reports cover key developments in the therapeutic drug monitoring market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from therapeutic drug monitoring market are anticipated to lucrative growth opportunities in the future with the rising demand for therapeutic drug monitoring in the global market. Below mentioned is the list of few companies engaged in the therapeutic drug monitoring market.
The report also includes the profiles of key therapeutic drug monitoring market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Therapeutic drug monitoring is branch of clinical chemistry and clinical pharmacology. It helps to measure and maintain uniform drug concentration in the patients' blood stream for better outcome. Therapeutic drug monitoring is part of personalized medicine where measurement of medication concentration in the blood stream is necessary. Therapeutic drug monitoring is basically used in case of very specific drug concentrations requirement.
MARKET DYNAMICS
Therapeutic drug monitoring market is anticipated to grow in the forecast period owing to driving factors such as rising demand for personalized medication treatment, advancements in research of pharmacogenomics and pharmacokinetics of drugs, rising prevalence of complex diseases like cancer (rheumatoid arthritis, non-Hodgkin lymphomas), respiratory diseases such as neonatal apnea, pulmonary asthma, embolism and chronic obstructive pulmonary disease (COPD). Rising investments in research and development infrastructure by private players and government will drive the therapeutic drug monitoring market in near future. However, high infrastructure cost and lack of skilled professionals are the restraints of the therapeutic drug monitoring market.
MARKET SCOPE
The "Global Therapeutic Drug Monitoring Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of therapeutic drug monitoring market with detailed market segmentation by product, technology, drug class, end user, and geography. The global therapeutic drug monitoring market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading therapeutic drug monitoring market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global therapeutic drug monitoring market is segmented on the basis of product, technology, drug class, and end user. Based on product, the market is segmented as Equipment and consumables. On the basis of technology, the global therapeutic drug monitoring market is segmented in to immunoassays, chromatography-Ms, radioimmunoassays, and others. By drug class, the market is segmented into antibiotic drugs, antiepileptic drugs, antiarrhythmic drugs, bronchodilator drugs, immunosuppressant drugs, psychoactive drugs, anti-cancer drugs, and other drugs. On the basis of end user, the global therapeutic drug monitoring market is divided into hospital laboratories, private laboratories and other laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global therapeutic drug monitoring market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The therapeutic drug monitoring market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting therapeutic drug monitoring market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the therapeutic drug monitoring market in these regions.
Therapeutic Drug Monitoring Market Report Analysis
Therapeutic Drug Monitoring Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott Laboratories
- Agilent Technologies Inc
- Bio Rad Laboratories Inc
- bioMerieux SA
- B hlmann Laboratories AG
- Danaher Corporation
- F Hoffmann La Roche Ltd
- Randox Laboratories Ltd
- Siemens Healthineers
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- Equipment and Consumables
By Technology
- Immunoassays
- Chromatography-MS
- Radioimmunoassays
By Drug Class
- Antibiotic Drugs
- Antiepileptic Drugs
- Antiarrhythmic Drugs
- Bronchodilator Drugs
- Immunosuppressant Drugs
- Psychoactive Drugs
- Anti-cancer Drugs
- Other Drugs
By End User
- Hospital Laboratories
- Private Laboratories
- Other Laboratories
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The reports cover key developments in the therapeutic drug monitoring market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from therapeutic drug monitoring market are anticipated to lucrative growth opportunities in the future with the rising demand for therapeutic drug monitoring in the global market. Below mentioned is the list of few companies engaged in the therapeutic drug monitoring market.
The report also includes the profiles of key therapeutic drug monitoring market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Bühlmann Laboratories AG
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Randox Laboratories Ltd.
- Sekisui Medical Co. Ltd.
- Siemens Healthineers
- Thermo Fisher Scientific
Therapeutic Drug Monitoring Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. Bio-Rad Laboratories Inc.
4. bioMerieux SA
5. Bühlmann Laboratories AG
6. Danaher Corporation
7. F. Hoffmann-La Roche Ltd
8. Randox Laboratories Ltd.
9. Siemens Healthineers
10. Thermo Fisher Scientific
1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. Bio-Rad Laboratories Inc.
4. bioMerieux SA
5. Bühlmann Laboratories AG
6. Danaher Corporation
7. F. Hoffmann-La Roche Ltd
8. Randox Laboratories Ltd.
9. Siemens Healthineers
10. Thermo Fisher Scientific
Get Free Sample For